Indian data on central nervous tumors: A summary of published work
A Dasgupta, T Gupta, R Jalali - South Asian journal of cancer, 2016 - thieme-connect.com
Tumors of the central nervous system (CNS) constitute approximately 2% of all
malignancies. Although relatively rare, the associated morbidity and mortality and the …
malignancies. Although relatively rare, the associated morbidity and mortality and the …
Radiotherapy-associated Sensorineural Hearing Loss in Pediatric Oncology Patients
MA Aslam, H Ahmad, HS Malik… - Current Medicinal …, 2024 - benthamdirect.com
During the radiotherapeutic treatment of pediatric oncology patients, they would be at a
latent risk of developing ionizing radiation-induced ototoxicity when the cochlea or auditory …
latent risk of developing ionizing radiation-induced ototoxicity when the cochlea or auditory …
Risk factors for treatment-related sensorineural hearing loss and hearing aid use in medulloblastoma patients: An observational cohort study
FM Troschel, DR Steike, J Roers, C Kittel… - Strahlentherapie und …, 2024 - Springer
Purpose This study aimed to analyze treatment-related risk factors for sensorineural hearing
loss (SNHL) and an indication for hearing aids (IHA) in medulloblastoma patients after …
loss (SNHL) and an indication for hearing aids (IHA) in medulloblastoma patients after …
[PDF][PDF] Audiometric findings in patients with head and neck chemoradiotherapy and radiotherapy: short-term outcomes
Background: Hearing loss is a major concern in the patient with head and neck cancer
(HNC) undergoing radiotherapy (RT) and/or chemotherapy (CHT). The present study aimed …
(HNC) undergoing radiotherapy (RT) and/or chemotherapy (CHT). The present study aimed …
Neurocognitive function and survival in children with average-risk medulloblastoma treated with hyperfractionated radiation therapy alone: Long-term mature …
T Gupta, B Kalra, S Goswami, J Deodhar… - Neuro-oncology …, 2022 - academic.oup.com
Background The purpose of this study was to report long-term neurocognitive and clinical
outcomes in children treated for average-risk medulloblastoma with hyperfractionated …
outcomes in children treated for average-risk medulloblastoma with hyperfractionated …
[HTML][HTML] 39. Wissenschaftliche Jahrestagung der Deutschen Gesellschaft für Phoniatrie und Pädaudiologie (DGPP)
F Burk, L Traser, M Burdumy, B Richter, M Echternach - egms.de
Hintergrund: Das Messa di voce (MdV) ist ein wichtiger Bestandteil der westlichen
klassischen Gesangstechnik und besteht in einem An-und Abschwellen der Lautstärke …
klassischen Gesangstechnik und besteht in einem An-und Abschwellen der Lautstärke …
[HTML][HTML] 36. Wissenschaftliche Jahrestagung der Deutschen Gesellschaft für Phoniatrie und Pädaudiologie (DGPP)
R Parfitt, A Tillmanns, P Matulat, D Deuster, S Elsner… - egms.de
Background: Cisplatin and carboplatin are widely used in paediatric cancer treatment.
Cisplatin especially can have long-term side effects, including sensorineural hearing loss …
Cisplatin especially can have long-term side effects, including sensorineural hearing loss …
Identification of MYCN and SOX9 target genes and a study of drug treatment effects in medulloblastoma
T Östergren - 2015 - diva-portal.org
The most common pediatric malignant primary brain tumor is Medulloblastoma (MB), a
cancer that originates in the hindbrain (cerebellum) and only rarely affects adults (1, 2) …
cancer that originates in the hindbrain (cerebellum) and only rarely affects adults (1, 2) …